Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | July 27, 2026 | July 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date July 27, 2026 · Filed July 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 507,675 |
Reported balance
After 2026-07-27 transaction · row 1
1 source rowRow 1 · 2026-07-27 · Gift · Disposed 2,500 · Balance 507,675 |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Davidar Family Irrevocable Trust U/A 8/6/09 | 165,967 |
Reported balance
Holding disclosure · report date 2026-07-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 165,967 F1: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2026 Filed Jul 28, 2026 22:22 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-321442 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507,675 Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:04 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001193125-26-263997 · ownership.xml · derivative · entry 4 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:04 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 25,000 | $80.76 | $2,019,072.50 |
DisclosureSEC source: 0001193125-26-263997 · ownership.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,175 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $80.59 - $80.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:04 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 25,000 | $26.27 | $656,750.00 |
DisclosureSEC source: 0001193125-26-263997 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 535,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:44 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021172 · ownership.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and will vest on January 1, 2027. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 22:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001193125-25-280500 · ownership.xml · derivative · entry 4 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 22:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 25,000 | $86.00 | $2,150,005.00 |
DisclosureSEC source: 0001193125-25-280500 · ownership.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,275 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $86.00 - $86.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 22:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 25,000 | $25.52 | $638,000.00 |
DisclosureSEC source: 0001193125-25-280500 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 23:18 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047058 · ownership.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and will vest on January 1, 2026. Read SEC document |
| January 02, 2025 Filed Jan 5, 2026 23:54 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-002966 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,175 Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:35 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 6,746 | $85.00 | $573,434.96 |
DisclosureSEC source: 0000950170-24-130603 · ownership.xml · nonDerivative · entry 4 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Davidar Family Irrevocable Trust Disclosed balance after: 165,967 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 23, 2023 executed by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $85.00 - $85.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (3) of this Form 4. F2 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:35 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 6,766 | $85.00 | $575,135.03 |
DisclosureSEC source: 0000950170-24-130603 · ownership.xml · nonDerivative · entry 3 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 516,275 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 23, 2023 executed by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $85.00 - $85.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:35 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 13,254 | $85.00 | $1,126,590.00 |
DisclosureSEC source: 0000950170-24-130603 · ownership.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Davidar Family Irrevocable Trust Disclosed balance after: 172,713 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 23, 2023 executed by the reporting person. F2 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:35 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 13,234 | $85.00 | $1,124,890.00 |
DisclosureSEC source: 0000950170-24-130603 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 523,041 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 23, 2023 executed by the reporting person. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 20,000 | $75.03 | $1,500,610.00 |
DisclosureSEC source: 0000950170-24-115615 · ownership.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Davidar Family Irrevocable Trust Disclosed balance after: 185,967 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 14, 2023 executed by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $75.00 - $75.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (3) of this Form 4. F4 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 30,000 | $75.04 | $2,251,203.00 |
DisclosureSEC source: 0000950170-24-115615 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 536,275 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 14, 2023 executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $75.00 - $75.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0000950170-24-107316 · ownership.xml · derivative · entry 4 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 25,000 | $70.46 | $1,761,500.00 |
DisclosureSEC source: 0000950170-24-107316 · ownership.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,275 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $70.20 - $70.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 25,000 | $25.52 | $638,000.00 |
DisclosureSEC source: 0000950170-24-107316 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 591,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:48 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 20,000 | $65.00 | $1,300,000.00 |
DisclosureSEC source: 0000950170-24-057917 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 566,275 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 14, 2023 executed by the reporting person. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:58 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008936 · ownership.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and will vest on January 1, 2025. Read SEC document |
| January 18, 2024 Filed Jan 25, 2024 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-007466 · ownership.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 586,275 Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 21:54 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013226 · doc4.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 21:00 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 31,500 | $78.03 | $2,458,071.00 |
DisclosureSEC source: 0001209191-22-025191 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,275 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.15, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 14, 2022 Filed Jan 18, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003770 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,275 Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005599 · doc4.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 08, 2021 Filed Feb 7, 2022 21:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007492 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,775 Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:58 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004044 · doc4.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 21:26 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 10,000 | $60.00 | $600,000.00 |
DisclosureSEC source: 0001209191-20-060642 · doc4.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Davidar Family Irrevocable Trust U/A 8/6/09 Disclosed balance after: 205,967 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 21:26 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 32,000 | $60.00 | $1,920,000.00 |
DisclosureSEC source: 0001209191-20-060642 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,775 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:45 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004860 · doc4.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 21:40 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 10,000 | $54.04 | $540,400.00 |
DisclosureSEC source: 0001209191-19-056043 · doc4.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Davidar Family Irrevocable Trust U/A 8/6/09 Disclosed balance after: 215,967 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · ownership.nature: These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 21:40 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 38,000 | $54.00 | $2,052,000.00 |
DisclosureSEC source: 0001209191-19-056043 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,775 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 50,000 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001209191-19-046594 · doc4.xml · derivative · entry 4 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 50,000 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 20, 2015, and vested over a four-year period with one-fourth (1/4) of the options granted having vested on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted having vested ratably on a monthly basis over the following 36 months. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 50,000 | $49.33 | $2,466,505.00 |
DisclosureSEC source: 0001209191-19-046594 · doc4.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,775 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.30 to $49.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 50,000 | $24.10 | $1,205,000.00 |
DisclosureSEC source: 0001209191-19-046594 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 20:41 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019177 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,775 Read SEC document |
| January 22, 2019 Filed Feb 11, 2019 21:41 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0001209191-19-008972 · doc4.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2029-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 20:18 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass A Common Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020169 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,775 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · derivative · entry 10 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,000 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $13.04 | $0.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · derivative · entry 9 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $15.34 | $0.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · derivative · entry 8 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,000 shares Expires 2022-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 30,000 | $50.50 | $1,515,009.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · nonDerivative · entry 6 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,775 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 30,000 | $23.95 | $718,500.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · nonDerivative · entry 5 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 25,000 | $50.50 | $1,262,507.50 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · nonDerivative · entry 4 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,775 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 25,000 | $13.04 | $326,000.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · nonDerivative · entry 3 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 758,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 15,000 | $50.50 | $757,504.50 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · nonDerivative · entry 2 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,775 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 15,000 | $15.34 | $230,100.00 |
DisclosureSEC source: 0001209191-18-018864 · doc4.xml · nonDerivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 21:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-18-005113 · doc4.xml · derivative · entry 1 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2028-01-22 F1 · derivative.exercise_date: These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on March 31, 2018, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 21:11 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 18,461 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-17-064177 · doc4.xml · derivative · entry 10 Davidar David D · CIK 0001555268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18,461 shares Expires 2021-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.